SIR Peng Tee Khaw, that is!

• No Comments

07/09/2013

One of our former guest speakers (2005 — Eye on the Bayou), Peng Tee Khaw, Professor of Glaucoma and Ocular Healing and Consultant Ophthalmic Surgeon at Moorfields Eye Hospital and UCL Institute of Ophthalmology, has been knighted.

One of our former guest speakers, Peng Tee Khaw, Professor of Glaucoma and Ocular Healing and Consultant Ophthalmic Surgeon at Moorfields Eye Hospital and UCL Institute of Ophthalmology, has been knighted in the Queen’s Birthday Honours for 2013.

Professor Khaw said: “I am very humbled to have been awarded this incredible honour. I feel I have received this on behalf of all my colleagues here at Moorfields, UCL and around the world with whom I have been privileged to work, and who transform the lives of so many people every day.”

Professor Khaw’s long track record of innovative research includes developing new therapies, particularly for scarring. He has developed surgical techniques (such as the Moorfields Safer Surgery System) which have markedly improved the safety and outcome of glaucoma surgery, and developed new anti-scarring regimens based on laboratory research, leading to large international clinical trials and use. These treatments and techniques have been successfully adapted for use in many parts of the developing world at minimal cost. He and his team have been awarded over 20 national and international prizes.

As part of the translational activities at the UCL Institute of Ophthalmology and the Biomedical Research Centre in Ophthalmology at Moorfields Eye Hospital, Professor Khaw is currently working with UCL Business (UCLB) to develop two new ophthalmic technologies for glaucoma:

  • ‘slow-release’ micro-tablet which allows prolonged dosage of anti-scarring agent to the eye, thus preventing fibrosis and blindness post-surgery. This micro-tablet contains matrix metalloprotease inhibitors which inhibit scarring and increase the success of glaucoma filtration surgery. The development of this technology is currently funded by and MRC DPFS award.
  • a solid formulation methodology for antibodies and protein therapeutics delivery into the eye. This tablet provides prolonged release of the antibody therapeutics and reduces the need for repeat injections.

Congratulations, SIR Khaw!

 

Comments are closed.